Roger A. Kroes - Lake Zurich IL Joseph R. Moskal - Chicago IL Hirotaka Yamamoto - Glenview IL
Assignee:
Nyxis NeuroTherapies, Inc. - Chicago IL
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 221, 536 243, 544313
Abstract:
The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
Roger A. Kroes - Lake Zurich IL Joseph R. Moskal - Chicago IL Hirotaka Yamamoto - Glenview IL
Assignee:
NYXIS NeuroTherapies, Inc. - Chicago IL
International Classification:
C12Q 168 C12P 1934 C07H 2102 C07H 2104
US Classification:
435 6
Abstract:
The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.